Amgen ٢٠ أبريل ٢٠٢٦ Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
FierceBiotech ١٦ أبريل ٢٠٢٦ Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech ٦ أبريل ٢٠٢٦ With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine
FierceBiotech ١ أبريل ٢٠٢٦ Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
FierceBiotech ١ أبريل ٢٠٢٦ Oric chases Pfizer into phase 3 hailing prostate cancer edge, but investors send stock down
BioPharma Dive ٢٣ مارس ٢٠٢٦ Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
FierceBiotech ٢٣ مارس ٢٠٢٦ Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push
FierceBiotech ١٢ مارس ٢٠٢٦ Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out
BioPharma Dive ٦ مارس ٢٠٢٦ Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs
Endpoints News ٦ مارس ٢٠٢٦ Pfizer gets obesity drug approval in China shortly after buying local rights